Can Digital Health Improve Therapeutic Compliance in Oncology?
JCO Clinical Cancer Informatics · 2024
DOI: 10.1200/cci-24-00205 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift JCO Clinical Cancer Informatics, 2024. Verfasst von Pierre Etienne Heudel und 4 weiteren Autor:innen. Beteiligte Einrichtung: Medical Oncology Department, Centre Léon Bérard, Lyon, France. Hauptthemen laut MEDLINE: Telemedicine, Neoplasms, Medical Oncology, Medication Adherence. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 45 Literaturangaben.
Themen: Digitalisierung in der Pflege
Abstract (Originalsprache)
PURPOSE Therapeutic compliance, or adherence, is critical in oncology because of the complexity and duration of cancer treatment regimens. Nonadherence can lead to suboptimal therapeutic outcomes, increased disease progression, higher mortality rates, and elevated health care costs. Traditional methods to enhance compliance, such as patient education and regular follow-ups, have shown limited success. MATERIALS AND METHODS This review examines the potential of digital health technologies to improve adherence in oncology. Various studies and trials are analyzed to assess the effectiveness of these technologies in supporting patients with cancer. RESULTS mHealth applications have been shown to improve medication adherence through features like medication reminders and symptom tracking. Telemedicine facilitates continuous care and reduces the need for travel, significantly improving adherence and patient satisfaction. Patient-reported outcome measures enhance clinical decision making and personalized treatment plans by incorporating patient feedback. Electronic medical records and patient portals improve compliance by providing easy access to medical information and fostering better patient-provider communication. Connected pillboxes aid in consistent medication intake and reduce dispensing errors. CONCLUSION Digital health technologies offer significant benefits in oncology by enhancing patient engagement, improving adherence to treatment protocols, and enabling comprehensive cancer care management. However, challenges such as the digital divide, data privacy concerns, and the need for tailored interventions must be addressed. Future research should focus on evaluating the effectiveness of digital interventions and developing personalized digital health tools to maximize therapeutic compliance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Medical Oncology Department, Centre Léon Bérard, Lyon, France.
- Department of Pharmacy, Centre Léon Bérard, Lyon, France.
- Head of Data Factory, Centre Léon Bérard, Lyon, France.
ORCID-Profile: Pierre Etienne Heudel, Myriam Ait Ichou, Hugo Crochet, Jean-Yves Blay
Zitieren
APA
Heudel, P. E., Ait Ichou, M., Favier, B., Crochet, H., & Blay, J. Y. (2024). Can Digital Health Improve Therapeutic Compliance in Oncology?. JCO Clinical Cancer Informatics. https://doi.org/10.1200/cci-24-00205
Vancouver
Heudel PE, Ait Ichou M, Favier B, Crochet H, Blay JY. Can Digital Health Improve Therapeutic Compliance in Oncology?. JCO Clinical Cancer Informatics. 2024. doi:10.1200/cci-24-00205
BibTeX
@article{Heudel2024,
author = {Heudel, Pierre Etienne and Ait Ichou, Myriam and Favier, Bertrand and Crochet, Hugo and Blay, Jean-Yves},
title = {Can Digital Health Improve Therapeutic Compliance in Oncology?},
journal = {JCO Clinical Cancer Informatics},
year = {2024},
doi = {10.1200/cci-24-00205}
}
EUVIMED